These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34928249)

  • 1. Long-Term Multilevel Intervention Impact on Human Papillomavirus Vaccination Rates Spanning the COVID-19 Pandemic.
    Casey SM; Jansen E; Drainoni ML; Schuch TJ; Leschly KS; Perkins RB
    J Low Genit Tract Dis; 2022 Jan; 26(1):13-19. PubMed ID: 34928249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination: A Cluster Randomized Clinical Trial.
    Dempsey AF; Pyrznawoski J; Lockhart S; Barnard J; Campagna EJ; Garrett K; Fisher A; Dickinson LM; O'Leary ST
    JAMA Pediatr; 2018 May; 172(5):e180016. PubMed ID: 29507952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Outcomes of a Multilevel Human Papillomavirus Vaccination Pilot Intervention in Federally Qualified Health Centers.
    Fisher-Borne M; Preiss AJ; Black M; Roberts K; Saslow D
    Acad Pediatr; 2018 Mar; 18(2S):S79-S84. PubMed ID: 29502642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a Multilevel Quality Improvement Intervention Using National Partnerships on Human Papillomavirus Vaccination Rates.
    Perkins RB; Foley S; Hassan A; Jansen E; Preiss S; Isher-Witt J; Fisher-Borne M
    Acad Pediatr; 2021; 21(7):1134-1141. PubMed ID: 34023489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States.
    Goel K; Vasudevan L
    Hum Vaccin Immunother; 2021 Dec; 17(12):5390-5396. PubMed ID: 34736353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis.
    Daniels V; Saxena K; Roberts C; Kothari S; Corman S; Yao L; Niccolai L
    Vaccine; 2021 May; 39(20):2731-2735. PubMed ID: 33875269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Papillomavirus Vaccinations During the COVID-19 Pandemic in Middle Schools in the Rio Grande Valley of Texas.
    Rodriguez AM; Do TQN; Jibaja-Weiss ML; Chen L; Schmeler KM; Montealegre JR; Kuo YF
    Am J Public Health; 2022 Sep; 112(9):1269-1272. PubMed ID: 35862887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 Pandemic on Human Papillomavirus Vaccine Uptake in Israel.
    Lavie M; Lavie I; Laskov I; Cohen A; Grisaru D; Grisaru-Soen G; Michaan N
    J Low Genit Tract Dis; 2023 Apr; 27(2):168-172. PubMed ID: 36815631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Training Pediatric Clinicians in Human Papillomavirus Communication Strategies on Human Papillomavirus Vaccination Rates: A Cluster Randomized Clinical Trial.
    Szilagyi PG; Humiston SG; Stephens-Shields AJ; Localio R; Breck A; Kelly MK; Wright M; Grundmeier RW; Albertin C; Shone LP; Steffes J; Rand CM; Hannan C; Abney DE; McFarland G; Kominski GF; Seixas BV; Fiks AG
    JAMA Pediatr; 2021 Sep; 175(9):901-910. PubMed ID: 34028494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus (HPV) vaccine coverage rates (VCRs) in France: A French claims data study.
    Dalon F; Majed L; Belhassen M; Jacoud F; Bérard M; Lévy-Bachelot L; de Pouvourville G; Rouzier R; Raude J; Baldauf JJ
    Vaccine; 2021 Aug; 39(36):5129-5137. PubMed ID: 34334252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Papillomavirus Vaccine Coverage and Prevalence of Missed Opportunities for Vaccination in an Integrated Healthcare System.
    Irving SA; Groom HC; Stokley S; McNeil MM; Gee J; Smith N; Naleway AL
    Acad Pediatr; 2018 Mar; 18(2S):S85-S92. PubMed ID: 29502643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing Human Papillomavirus Vaccination in a Federally Qualified Health Center Organization Using a Systems-Based Intervention Integrating EHR and Statewide Immunization Information System.
    Vinci DM; Ryan J; Howard M; Snider D; Strahan B; Smith G; McClain R
    J Community Health; 2022 Feb; 47(1):53-62. PubMed ID: 34333719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV immunization among young adults (HIYA!) in family practice: A quality improvement project.
    Eisenhauer L; Hansen BR; Pandian V
    J Adv Nurs; 2022 May; 78(5):1366-1376. PubMed ID: 34806202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the COVID-19 Pandemic on Human Papillomavirus Vaccination in Brazil.
    Silva TMRD; Nogueira de Sá ACMG; Beinner MA; Abreu MNS; Matozinhos FP; Sato APS; Vieira EWR
    Int J Public Health; 2022; 67():1604224. PubMed ID: 35431762
    [No Abstract]   [Full Text] [Related]  

  • 15. Implementation and evaluation of a multilevel intervention to increase uptake of the human papillomavirus vaccine among rural adolescents.
    Dang JHT; McClure S; Gori ACT; Martens T; Mojadedi A; Smith U; Austin CJ; Chen MS
    J Rural Health; 2023 Jan; 39(1):136-141. PubMed ID: 35798683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California.
    Chao CR; Xu L; Cannizzaro N; Bronstein D; Choi Y; Riewerts R; Mittman B; Zimmerman RK; Gilkey M; Glenn B; Shen E; Hsu C; Hahn EE
    Vaccine; 2022 Nov; 40(46):6575-6580. PubMed ID: 36243591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the impact of multilevel evidence-based implementation strategies to enhance provider recommendation on human papillomavirus vaccination rates among an empaneled primary care patient population: a study protocol for a stepped-wedge cluster randomized trial.
    Finney Rutten LJ; Radecki Breitkopf C; St Sauver JL; Croghan IT; Jacobson DJ; Wilson PM; Herrin J; Jacobson RM
    Implement Sci; 2018 Jul; 13(1):96. PubMed ID: 30001723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13?
    O'Leary SC; Frost HM
    Hum Vaccin Immunother; 2023 Dec; 19(1):2180971. PubMed ID: 36892245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared Determinants for Human Papillomavirus and COVID-19 Vaccination Intention: An Opportunity for Resource Consolidation.
    Olagoke AA; Carnahan LR; Olagoke O; Molina Y
    Am J Health Promot; 2022 Mar; 36(3):506-509. PubMed ID: 34738469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disentangling the Role of Religiosity in Human Papillomavirus Vaccination Amidst COVID-19 Pandemic.
    Olagoke AA; Floyd B; Caskey R; Hebert-Beirne J; Boyd AD; Molina Y
    J Relig Health; 2022 Apr; 61(2):1734-1749. PubMed ID: 35112233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.